search
Back to results

Brief Motivational Therapy Versus Usual Care for Alcohol Use Disorders in Primary Care.

Primary Purpose

Alcohol Use Disorder

Status
Recruiting
Phase
Not Applicable
Locations
Chile
Study Type
Interventional
Intervention
Brief motivational treatment
Enhanced Usual Care
Sponsored by
Nicolás Barticevic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Alcohol Use Disorder focused on measuring Primary care, Alcohol use disorder, Motivational interview

Eligibility Criteria

20 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Clinical diagnosis of alcohol use disorder according to the DSM-V (American Psychiatric Association, 2013
  • Must fulfill criteria for alcohol use disorder and criteria for harmful alcohol use during the last month, i.e., five or more heavy drinking occasions in the last month (5 or more drinks in men, 4 or more in women), or an average use of 14 or more drinks a week in men, and 7 or more in women
  • Also, alcohol use should be the main problem motivating participants to seek treatment.

Exclusion Criteria:

  • Clients under 20 years old
  • Clients in whom alcohol use is not the main problem
  • Clients who leave the area or are unable for follow-up contact
  • Clients with severe mental comorbidity
  • Clients with severe cognitive impairment, illiteracy, or unable to follow treatment in Spanish.
  • Clients who are concurrently receiving or planning to receive other psychosocial treatment for alcohol use disorder other than usual care, i.e., formal professional treatment outside of primary care. Participation in community services and Alcoholics Anonymous is permissible.
  • Clients who have previously participated in the study, or whose family members are or have been participants.

Sites / Locations

  • CESFAM Juan Pablo IIRecruiting
  • CESFAM Madre Teresa de CalcutaRecruiting
  • CESFAM San Alberto HurtadoRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Brief motivational treatment

Enhanced usual care

Arm Description

Participants in the intervention group will receive the Brief Motivational Treatment, which is a primary care-adaptation of the Motivational Enhancement Therapy as manualized in the Project MATCH [19]. This treatment consists of four 45-minute sessions, provided by a psychologist at weeks one, two, six, and twelve. The first three sessions, occurring during the first six weeks, are more active regarding the behavioural change, while the last session functions as closure and review of the process. If a participant asks for more support, they will be able to attend up to two extra sessions before the last one. The main adaptations are: The translation into Chilean Spanish. Update of Motivational Interview concepts. Companion training material that includes a demonstrative video and practical exercises. An adapted personalized feedback procedure. Information on additional resources available in the primary care centre and the community.

All participants will receive an educational brochure on alcohol use disorder, with self-help materials and guides on how to get additional support. The physicians within the PC centre will also receive information on how to diagnose alcohol use disorders, prescription guides for the medications that are available for treating these disorders in the PC centre (mainly Disulfiram and any other if available), and directions on when and where to refer clients for treatment.

Outcomes

Primary Outcome Measures

Change in the Drinks per Drinking Day (DDD)
The change from baseline in the DDD during the last 90 days. The DDD will be aggregated using means.

Secondary Outcome Measures

Change in the alcohol use pattern
The number of participants with a low-risk alcohol use pattern estimated by the number of days of consumption, of abstinence, and intoxication during the last 90 days, aggregated using the proportion of participants per group.
Abstinence days
The most extended period of abstinence since enrolment. The number of abstinence days of each participant will be aggregated using means.
Change in the negative consequences of alcohol use
The change from baseline in the negative secondary consequences of alcohol consumption will be measured using the Drinker Inventory of Consequences (DrInC-2R) questionnaire, and will be aggregated using means. The DrInC-2R has a score range from 0 to 150, with higher scores indicating higher consequences.
Change in the severity of the dependency
The change from baseline in the severity of the alcohol use disorder using the Substance Dependence Severity Scale. Means will be used to aggregate participants' DAYS, SEV, and WORST SEV scores for alcohol. The DAYS score varies on an 8-point scale ranging from 0 (symptom did not occur) to 7 (symptom occurred every day of past 30). The SEV and WORST SEV severity variables are scored on a 6-point scale ranging from 0 (absent) to 5 (extreme), with a score of '2' indicating that the diagnostic criterion has been met. Lower scales scores represent less severe dependence, and higher scale scores reflect more severe dependence.
Change in the motivation for change
The change from baseline in the motivational stage measured with the Stages of Change Readiness and Treatment Eagerness Scale-Drug (SOCRATES). The proportion of participants that improve their motivational stage will be used to aggregate the measurement in each group. The SOCRATES scores range within three dimensions: Recognition (7 - 35), Ambivalence (4 - 20), and Taking Steps (8 - 40), with higher scores indicating higher involvement in the dimension.

Full Information

First Posted
April 8, 2020
Last Updated
December 20, 2021
Sponsor
Nicolás Barticevic
Collaborators
Fondo Nacional de Desarrollo Científico y Tecnológico, Chile
search

1. Study Identification

Unique Protocol Identification Number
NCT04345302
Brief Title
Brief Motivational Therapy Versus Usual Care for Alcohol Use Disorders in Primary Care.
Official Title
Brief Motivational Therapy Versus Enhanced Usual Care for Alcohol Use Disorder in Primary Care in Chile, an Exploratory Randomised Trial
Study Type
Interventional

2. Study Status

Record Verification Date
December 2021
Overall Recruitment Status
Recruiting
Study Start Date
November 1, 2021 (Actual)
Primary Completion Date
November 2022 (Anticipated)
Study Completion Date
November 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Nicolás Barticevic
Collaborators
Fondo Nacional de Desarrollo Científico y Tecnológico, Chile

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Harmful alcohol use is a leading cause of global disability and death. However increased detection and brief intervention capacity of more severe alcohol use disorders (AUD) has not been accompanied by increased availability of treatment services. Incorporating treatment for such disorders into primary care (PC) is of paramount importance for improving access and health outcomes. This study aims to estimate the effectiveness of a Brief Motivational Treatment (BMT) applied in primary care for treatment of these disorders. This trial aims to test the superiority of BMT over enhanced usual care with a reasonable margin, over which the BMT could be further considered for incorporation into PC in Chile. Its pragmatic approach ultimately aims to inform policymakers about the benefit of including a brief psychosocial treatment into PC.
Detailed Description
This exploratory trial aims to estimate the effectiveness of a BMT for AUD provided in PC. The underlying question is whether Chilean PC should incorporate this treatment among its regular programs based on its effectiveness. To answer this question, a randomised comparison between the manualized BMT and EUC will be undertaken. The main hypothesis is a superiority one: • Participants under BMT will perform better than EUC in the reduction of alcohol consumption. Also, there are ancillary questions that deserve special attention. The following hypotheses will help with the explanation of the results: Active BMT components (i.e., the working alliance and fidelity to the MI strategies) mediate the effect. Participant´s AUD severity mediates the effect. Participants under BMT will receive a higher amount of additional care (physician consultations, social worker consultations, participation in alcoholic anonymous, and others).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alcohol Use Disorder
Keywords
Primary care, Alcohol use disorder, Motivational interview

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The study is a parallel-group, single-blinded, randomized clinical trial to test the superiority of a Brief Motivational Treatment over enhanced usual care. The allocation ratio is 1:1 as per a computer-generated randomisation schedule stratified by site and the baseline SDSS-DAYS score using permuted blocks of random sizes.
Masking
Outcomes Assessor
Masking Description
A research assistant blinded to the allocation of the participant will perform the follow-up assessments. Due to the nature of the intervention, the participants and the therapists will know in which group they are participating; however, they will be strongly instructed to not disclose their allocation at the follow-up assessments. At trial closure, a statistician blinded to allocation will conduct the data analysis.
Allocation
Randomized
Enrollment
182 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Brief motivational treatment
Arm Type
Experimental
Arm Description
Participants in the intervention group will receive the Brief Motivational Treatment, which is a primary care-adaptation of the Motivational Enhancement Therapy as manualized in the Project MATCH [19]. This treatment consists of four 45-minute sessions, provided by a psychologist at weeks one, two, six, and twelve. The first three sessions, occurring during the first six weeks, are more active regarding the behavioural change, while the last session functions as closure and review of the process. If a participant asks for more support, they will be able to attend up to two extra sessions before the last one. The main adaptations are: The translation into Chilean Spanish. Update of Motivational Interview concepts. Companion training material that includes a demonstrative video and practical exercises. An adapted personalized feedback procedure. Information on additional resources available in the primary care centre and the community.
Arm Title
Enhanced usual care
Arm Type
Active Comparator
Arm Description
All participants will receive an educational brochure on alcohol use disorder, with self-help materials and guides on how to get additional support. The physicians within the PC centre will also receive information on how to diagnose alcohol use disorders, prescription guides for the medications that are available for treating these disorders in the PC centre (mainly Disulfiram and any other if available), and directions on when and where to refer clients for treatment.
Intervention Type
Behavioral
Intervention Name(s)
Brief motivational treatment
Intervention Description
The treatment will be delivered by general psychologists with at least three years of experience in primary care. They will receive training and then will demonstrate proficiency in a simulated client session. During recruitment, therapy sessions will be recorded, and ten percent of them will be reviewed using a proficiency scale. Then, a feedback report will be issued and discussed with each therapist.
Intervention Type
Behavioral
Intervention Name(s)
Enhanced Usual Care
Intervention Description
During the trial, participants will continue to receive regular medical and social care at their health centre. These services may include prescriptions for mental health issues and alcohol (Disulfiram, anti-craving, anti-depressants, and other medications), social assistance, and the full spectrum of primary health care. Nevertheless, they will not receive other psychosocial interventions for alcohol use disorder in the health centre.
Primary Outcome Measure Information:
Title
Change in the Drinks per Drinking Day (DDD)
Description
The change from baseline in the DDD during the last 90 days. The DDD will be aggregated using means.
Time Frame
Baseline and six-months follow-up
Secondary Outcome Measure Information:
Title
Change in the alcohol use pattern
Description
The number of participants with a low-risk alcohol use pattern estimated by the number of days of consumption, of abstinence, and intoxication during the last 90 days, aggregated using the proportion of participants per group.
Time Frame
Baseline and six-months follow-up
Title
Abstinence days
Description
The most extended period of abstinence since enrolment. The number of abstinence days of each participant will be aggregated using means.
Time Frame
At six-months follow-up
Title
Change in the negative consequences of alcohol use
Description
The change from baseline in the negative secondary consequences of alcohol consumption will be measured using the Drinker Inventory of Consequences (DrInC-2R) questionnaire, and will be aggregated using means. The DrInC-2R has a score range from 0 to 150, with higher scores indicating higher consequences.
Time Frame
Baseline and six-months follow-up
Title
Change in the severity of the dependency
Description
The change from baseline in the severity of the alcohol use disorder using the Substance Dependence Severity Scale. Means will be used to aggregate participants' DAYS, SEV, and WORST SEV scores for alcohol. The DAYS score varies on an 8-point scale ranging from 0 (symptom did not occur) to 7 (symptom occurred every day of past 30). The SEV and WORST SEV severity variables are scored on a 6-point scale ranging from 0 (absent) to 5 (extreme), with a score of '2' indicating that the diagnostic criterion has been met. Lower scales scores represent less severe dependence, and higher scale scores reflect more severe dependence.
Time Frame
Baseline and six-months follow-up
Title
Change in the motivation for change
Description
The change from baseline in the motivational stage measured with the Stages of Change Readiness and Treatment Eagerness Scale-Drug (SOCRATES). The proportion of participants that improve their motivational stage will be used to aggregate the measurement in each group. The SOCRATES scores range within three dimensions: Recognition (7 - 35), Ambivalence (4 - 20), and Taking Steps (8 - 40), with higher scores indicating higher involvement in the dimension.
Time Frame
Baseline and six-months follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of alcohol use disorder according to the DSM-V (American Psychiatric Association, 2013 Must fulfill criteria for alcohol use disorder and criteria for harmful alcohol use during the last month, i.e., five or more heavy drinking occasions in the last month (5 or more drinks in men, 4 or more in women), or an average use of 14 or more drinks a week in men, and 7 or more in women Also, alcohol use should be the main problem motivating participants to seek treatment. Exclusion Criteria: Clients under 20 years old Clients in whom alcohol use is not the main problem Clients who leave the area or are unable for follow-up contact Clients with severe mental comorbidity Clients with severe cognitive impairment, illiteracy, or unable to follow treatment in Spanish. Clients who are concurrently receiving or planning to receive other psychosocial treatment for alcohol use disorder other than usual care, i.e., formal professional treatment outside of primary care. Participation in community services and Alcoholics Anonymous is permissible. Clients who have previously participated in the study, or whose family members are or have been participants.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Nicolas A Barticevic, MD
Phone
+56962225043
Email
nabartic@uc.cl
First Name & Middle Initial & Last Name or Official Title & Degree
Diego Quevedo
Email
daqueved@uc.cl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nicolas Barticevic, MD
Organizational Affiliation
Adjunct Professor School of Medicine Pontificia Universidad Catolica de Chile
Official's Role
Principal Investigator
Facility Information:
Facility Name
CESFAM Juan Pablo II
City
Santiago
Country
Chile
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Victoria Rodriguez
Email
mvrodriguez1@uc.cl
Facility Name
CESFAM Madre Teresa de Calcuta
City
Santiago
Country
Chile
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pedro Bustos
Email
artrigan@hotmail.com
Facility Name
CESFAM San Alberto Hurtado
City
Santiago
Country
Chile
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Victoria Rodriguez
Email
mvrodriguez1@uc.cl

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The full protocol, dataset, and statistical code are available in the Open Science Foundation repository, DOI 10.17605/OSF.IO/6BA3W
IPD Sharing Time Frame
From protocol registration on.
IPD Sharing Access Criteria
Public
IPD Sharing URL
https://doi.org/10.17605/OSF.IO/6BA3W
Citations:
PubMed Identifier
32736578
Citation
Barticevic NA, Poblete F, Zuzulich SM, Rodriguez V, Bradshaw L. Brief motivational therapy versus enhanced usual care for alcohol use disorders in primary care in Chile: study protocol for an exploratory randomized trial. Trials. 2020 Jul 31;21(1):692. doi: 10.1186/s13063-020-04589-4.
Results Reference
derived

Learn more about this trial

Brief Motivational Therapy Versus Usual Care for Alcohol Use Disorders in Primary Care.

We'll reach out to this number within 24 hrs